Physician profile
Parul Aneja
NPI 1205063393
$12,495.11
in general payments reported to CMS, 2019-2025
7 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $10K · 2021: $1,513 · 2022: $13.20 · 2023: $150 · 2024: $205 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $758 · Education: $13.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.74 |
| Education | $13.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $10,786.46 | 2020-2021 | |
| Abbvie INC. | $1,117.17 | 2021-2025 | Ubrelvy, Qulipta |
| Eisai INC. | $249.99 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $167.10 | 2021-2025 | Dysport |
| Genzyme Corporation | $97.42 | 2019 | |
| Abbott Laboratories | $63.57 | 2019 | |
| Neurelis, INC. | $13.40 | 2024 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parul Aneja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.